ClinicalTrials.gg
RecruitingNCT06803732Updated Jun 24, 2026

Postoperative Pain of Robotic, Endoscopic and Open Lateral Neck Dissection

An observational study in Pain, Postoperative, Thyroid Diseases and Surgery, sponsored by Shanghai 6th People's Hospital. Recruiting at 1 site in China. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by Shanghai 6th People's Hospital · Observational

From the registry’s dates

  • Started Nov 2024; still recruiting 2 years later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
600
Sex
All
01

Study summary

Postoperative pain is a good indicator to confirm the advantages of the surgical methods in the era of minimally invasive surgery. Lateral neck dissection requires extensive dissection which may leads to postoperative numbness and pain. Robotic thyroid surgery has the advantage of precise and careful dissection and avoid the L-shape incision in the open approach. The study aims to explore the pain intensity and severity of lateral neck dissection on operation day, postoperative month 1 and postoperative month 3 among the robotic, endoscopic and open approach.

02

Conditions studied

  • Pain, Postoperative
  • Thyroid Diseases
  • Surgery

Keywords

  • Lateral neck dissection
  • Robotic thyroid surgery
  • Minimally invasive surgery
03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's planned enrollment of 600 is above the median of 102 across 683 observational studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Shanghai 6th People's Hospital is the lead sponsor of 70 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with FNA proven differentiated thyroid cancer and metastatic lateral lymph nodes, underwent lateral neck dissection via robotic, endoscopic or open approach. Patients were well informed about the potential benefits and risks of robotic, endoscopic and open approach. Patient consented for us to use perioperative data.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients underwent lateral neck dissection via robotic, endoscopic or open approach
  • Clinical diagnosis of differentiated thyroid cancer
  • Clinical diagnosis of lateral lymph nodes

Exclusion criteria

Exclusion Criteria:

  • Participants with distant
  • Participants with history of neck surgery or radiation
  • Participants with vocal fold fixation by preoperative fibrolaryngoscope
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
600 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • Robotic group

    Patients underwent lateral neck dissection via robotic approach

    Other: Observations on postoperative pain intensity

  • Endoscopic group

    Patients underwent lateral neck dissection via endoscopic approach

    Other: Observations on postoperative pain intensity

  • Open group

    Patients underwent lateral neck dissection via open approach

    Other: Observations on postoperative pain intensity

Interventions

  • OtherObservations on postoperative pain intensity

    pain intensity was assessed using a standard visual analogue score, with a score of 0 to 10 corresponding to no pain to the most severe pain on operation day, postoperative day 1, postoperative month 1, postoperative month 3

06

What researchers measure

Primary outcomes

  1. degree of pain

    pain intensity was assessed using a standard visual analogue score, with a score of 0 to 10 corresponding to no pain to the most severe pain

    Time frame: approximately 4 hours after surgery, on postoperative day 1, postoperative month 1 and postoperative month 3

  2. Number of participants with recurrent laryngeal nerve injury

    impaired vocal cord mobility confirmed by postoperative laryngoscopy

    Time frame: through study completion, an average of 1 year

  3. Number of participants with hypoparathyroidism

    a postoperative parathyroid hormone level of less than 10 pg/ml

    Time frame: through study completion, an average of 1 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Data are available on request due to privacy or other restrictions. The data that support the findings of this study are available on request from Ling Zhan. The data are not publicly available due to them containing information that could compromise research participant privacy.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06803732
Lead sponsor
Shanghai 6th People's Hospital
Responsible party
Ling Zhan (Principal Investigator, Shanghai 6th People's Hospital) — Principal investigator
First posted
Jan 31, 2025
Start date
Nov 1, 2024
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Jun 24, 2026

Study contacts

Ling Zhan
Contact
15821120972@163.com
08615821120972
Ling Zhan, Dr
principal investigator · Shanghai 6th People's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion